Maciej Wieczorek, MD, discusses CPL'36, a new PDA101 inhibitor with a novel mechanism of action for treatment of schizophrenia.
Maciej Wieczorek, PhD
Advertisement
Articles by Maciej Wieczorek, PhD
Advertisement
Latest Updated Articles
Novel PDA10A Inhibitor for Schizophrenia in Development, Discussion With Maciej Wieczorek, PhDPublished: October 27th 2025 | Updated:
Advertisement
Advertisement
Trending on Psychiatric Times
1
Positive FDA Meeting for Abuse Deterrent Fentanyl Patch
2
Candy and Other Food Treats or Tricks
3
The Dangers of Conversion Therapy: What Chiles v Salazar Could Mean for LGBTQ+ Youth
4
Trick or Treat: Fiddling While Rome Burns or Playing a Violin of Hope?
5
